Section Arrow
BDSX.NASDAQ
- Biodesix
Quotes are at least 15-min delayed:2024/05/20 17:57 EDT
Last
 1.57
-0.005 (-0.32%)
Day High 
1.59 
Prev. Close
1.575 
1-M High
1.6317 
Volume 
110.84K 
Bid
1.56
Ask
1.57
Day Low
1.5501 
Open
1.59 
1-M Low
1.2 
Market Cap 
180.63M 
Currency USD 
P/E -- 
%Yield
10-SMA 1.54 
20-SMA 1.41 
50-SMA 1.39 
52-W High 2.21 
52-W Low 1.03 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.54/-0.22
Enterprise Value
241.02M
Balance Sheet
Book Value Per Share
-0.05
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
49.09M
Operating Revenue Per Share
0.38
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
EXASExact Sciences Corp51+0.62+1.23%-- 
DMTKDermTech0.3601-0.1394-27.91%-- 
GHGuardant Health24.77-0.59-2.33%-- 
ME23andMe Holding Co0.5466-0.0402-6.85%-- 
OPKOPKO Health1.32--0.000%-- 
Quotes are at least 15-min delayed:2024/05/20 17:57 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.